Biotech · Private company · Brookline, MA, US

Keylicon Biosciences Inc

Track this companyFree. Adds Keylicon Biosciences Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Low Dose Multivalent Influenza Vaccine via Modified Self-Amplifying RNAFiscal year 2026 · $314.4KNIH RePORTER 1R43AI197306-01 · fetched Nov 12, 2026
Multivalent Vaccine Against Lyme Disease via Modified Self-Amplifying RNAFiscal year 2026 · $314.4KNIH RePORTER 1R43AI197345-01 · fetched Nov 12, 2026
Extended In Situ Production of Glucocerebrosidase (GCase) for the Treatment of Gaucher DiseaseFiscal year 2026 · $400KNIH RePORTER 1R43DK146746-01 · fetched Nov 12, 2026
Improving the Stability of saRNA LNP Formulations To Overcome Cold Chain ChallengesFiscal year 2026 · $400KNIH RePORTER 1R43EB038819-01A1 · fetched Nov 12, 2026